Kim Chisholm
COO Neuroscience Business Unit @ Eli Lilly and Company
About Kim Chisholm
Kim Chisholm serves as the COO of the Neuroscience Business Unit at Eli Lilly and Company, a position he has held since 2021. He has a diverse background in consulting and management, with previous roles at AlixPartners, Deloitte, and various positions within Eli Lilly.